Reduces copayments and coinsurance for asthma inhalers covered by certain health benefits plans.
Impact
The proposed bill is expected to make asthma inhalers more affordable for individuals, particularly those who rely on them frequently. By establishing a lower threshold for out-of-pocket expenses, the bill seeks to enhance access to necessary medication for patients dealing with asthma. The modification applies to contracts executed or renewed after the bill's enactment. This standard applies universally across all state-regulated health plans, including those provided through the State and School Employees' Health Benefits Commissions, thus ensuring consistency in coverage for asthma inhalers statewide.
Summary
Senate Bill 3777, introduced by Senator Shirley K. Turner, focuses on reducing the financial burden for individuals prescribed asthma inhalers by lowering the copayment and coinsurance rates across state-regulated health insurance providers. Currently, the law stipulates a maximum copayment or coinsurance amount of $50 for a 30-day supply of prescription asthma inhalers. SB3777 aims to reduce this amount to $35. This change would impact various types of health insurance plans including individual and group hospital service corporations, medical service corporations, health service corporations, and health maintenance organizations.
Contention
While the intent of SB3777 is largely viewed positively, aimed at easing healthcare costs for individuals, there may be discussions regarding its overall impact on insurance premiums. Critics might argue that lowering copayments could compel insurance providers to adjust their pricing structures, potentially raising premiums in the long run. Nonetheless, supporters emphasize the need for improved access to essential medications and the importance of ensuring health equity for all state residents experiencing asthma.
Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.
Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.
Requires third-party discounts and payments for individuals covered by health benefits plans to apply to copayments, coinsurance, deductibles, or other out-of-pocket costs for covered benefits.
Requires third-party discounts and payments for individuals covered by health benefits plans to apply to copayments, coinsurance, deductibles, or other out-of-pocket costs for covered benefits.
An Act Concerning Health Insurance Coverage For Epinephrine Cartridge Injectors, Health Carriers, Pharmacy Benefits Managers And The Cost Impact Of Certain Mandated Health Insurance Benefits.
Requires Medicaid provide health benefits coverage, and places certain requirements on insurers and State Health Benefits Program regarding existing mandate on health benefits coverage, for certain over-the-counter contraceptives.
Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.
Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.
Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.